Dikhyaa Mohanty 
The US Food and Drug Administration (FDA) has expanded the emergency use authorization for the Pfizer-BioNTech Covid-19 vaccine boosters to children aged 12 to 15.
According to the reports, the FDA also shortened the time for booster shots from at least six months after completion of the initial series to at least five months, for everyone aged 12 and older. The agency has determined that the protective health benefits of a single booster dose of the Pfizer-BioNTech Covid-19 vaccine to provide continued protection against the virus and the associated serious consequences outweigh the potential risks in individuals aged 12 to 15.
The agency stated that it found no new safety concerns following a booster shot in young teenagers and that there were no new reports of two types of heart inflammation called myocarditis or pericarditis linked to the boosters.
